申请人:SANTEN PHARMACEUTICAL CO., LTD.
公开号:EP0711763A1
公开(公告)日:1996-05-15
A novel compound represented by general formula [I], wherein R¹ and R² may be the same or different from each other and each represents lower alkoxy; and A and B may be the same or different from each other and each represents lower alkylene. It has a σ receptor affinity and is useful as a remedy for diseases accompanying cranial nerve function disorder, such as dementia, depression, schizophrenia and anxiety, immunopathy and cryptorrhea, and digestive ulcer.
一种由通式[I]代表的新型化合物,其中R¹和R²可以彼此相同或不同,并且各自代表低级烷氧基;A和B可以彼此相同或不同,并且各自代表低级亚烷基。它具有σ受体亲和力,可用于治疗伴随颅神经功能紊乱的疾病,如痴呆、抑郁、精神分裂症和焦虑症、免疫病和隐性感染以及消化道溃疡。